STAT3 and pancreatic neoplasm: Of note, an in vivo mouse model of PC mimic obesity/T2DM demonstrated that metformin reduced desmoplasia in pancreatic tumor by directly inhibiting the AT1/TGF-β/STAT3 signaling and reducing release of collagen-I/HA by PSCs [174].